• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Raytel hangs on to listing

Article

Raytel’s one-for-three reverse stock split in May had the desired effect. The company narrowly escaped delisting from the Nasdaq smallcap. Raytel met Nasdaq requirements by keeping its stock price above $1 per share for 10 trading days following

Raytel’s one-for-three reverse stock split in May had the desired effect. The company narrowly escaped delisting from the Nasdaq smallcap. Raytel met Nasdaq requirements by keeping its stock price above $1 per share for 10 trading days following the split. On June 12, Raytel closed at $2.30.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.